IBI363 + chemotherapy Clinical Trials
2 recruitingDrug
Phase 21Phase 11
Showing 1–2 of 2 trials
Recruiting
Phase 2
Perioprative Study of IBI363 in Patients With MHC-II-Negative Locally Advanced Gastric Cancer
IBI363 + Chemotherapy
Zhejiang Cancer Hospital60 enrolled1 locationNCT07325630
Recruiting
Phase 1
A Study of IBI363 in Subjects With Advanced Malignancies
Advanced Malignancies
Innovent Biologics (Suzhou) Co. Ltd.556 enrolled1 locationNCT06468098